Related Experiment Video
Updated: Apr 16, 2026

10:38
Label-free Isolation and Enrichment of Cells Through Contactless Dielectrophoresis
Published on: September 3, 2013
16.8K
Enhancing sensitivity and specificity in rare cell capture microdevices with dielectrophoresis
James P Smith1, Chao Huang2, Brian J Kirby
1Sibley School of Mechanical and Aerospace Engineering, Cornell University , Ithaca, New York 14853, USA.
Biomicrofluidics
|March 12, 2015
Summary
This study optimizes microfluidic devices for rare cell capture, improving cancer diagnostics. Simulations show enhanced isolation of circulating tumor cells (CTCs) while reducing unwanted cell contamination.
Area of Science:
- Biomedical Engineering
- Cell Biology
- Microfluidics
Background:
- Rare cell isolation, like circulating tumor cells (CTCs), is crucial for disease understanding and treatment.
- High-purity isolation techniques are needed to reduce costs and improve genetic analysis of single cells.
- Previous research combined dielectrophoresis (DEP) with immunocapture for differential cell isolation.
Purpose of the Study:
- To develop numerical simulations for optimizing microfluidic obstacle array geometries.
- To maximize the capture of target rare cells (e.g., cancer cells) using DEP-immunocapture.
- To minimize the capture of contaminating cells (e.g., leukocytes) in microfluidic devices.
Main Methods:
- Numerical simulations of microfluidic obstacle array geometries.
- Investigating electrode placement and fluid flow dynamics.
- Analyzing dielectrophoretic (DEP) forces and cell responses (positive DEP - pDEP, negative DEP - nDEP).
Main Results:
- Optimized electrode configurations maximize electric field strength at obstacle edges.
- pDEP cells are attracted to low-shear, high-residence time regions, increasing capture probability.
- nDEP cells are repelled from high-capture regions, minimizing contamination.
Conclusions:
- Simulations predict significant reduction in contaminating peripheral blood mononuclear cell capture (0.16 to 0.01).
- Simulations predict increased capture of pancreatic cancer cell lines (0.03-0.10 to 0.14-0.55).
- This work provides a foundation for experimental studies of hybrid DEP-immunocapture microdevices for rare cell isolation.

